Nitric oxide and renal and cardiac dysfunction in cirrhosis

Clinical Science

Volumn 102, Issue 2, 2002, Pages 213-222

  García Estañ, Joaquín ^a   Ortiz, M Clara ^a   Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Ascites; Carbon monoxide; cGMP; Cirrhotic cardiomyopathy; Peroxynitrite; Sodium retention

Indexed keywords

ARACHIDONIC ACID; CARBON MONOXIDE; CYCLIC GMP; ISOPROSTANE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; PEROXYNITRITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOSYNTHESIS; BLOOD PRESSURE; CARDIOMYOPATHY; DISEASE SEVERITY; DIURESIS; ENZYME ACTIVATION; GAS ANALYSIS; HEART DISEASE; HEART MUSCLE CONTRACTILITY; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEROXIDATION; PRIORITY JOURNAL; RAT; REVIEW; SODIUM EXCRETION; SODIUM RETENTION; WATER RETENTION;

ANIMALS; ARACHIDONIC ACID; BODY WATER; CARDIOMYOPATHIES; HUMANS; KIDNEY DISEASES; LIVER CIRRHOSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PEROXYNITROUS ACID; RATS; SODIUM CHANNELS;

EID: 0036185331     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010154     Document Type: Review

References (102)

1. Nitric oxide as a signaling molecule in the vascular system: An overview
2. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
3. The role of nitric oxide in portal hypertensive systemic and portal vascular pathophysiology
4. Nitric oxide and portal hypertension: Its role in the regulation of intrahepatic and splanchnic vascular resistance
5. Underlying mechanisms of portal hypertensive gastropathy
6. Methylene blue and cirrhosis: Pathophysiologic insights, therapeutic dilemmas
7. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia
8. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis
9. Nitrite and nitrate levels in patients with cirrhosis of the liver: Influence of kidney function and fasting state
10. Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis
11. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis
12. Renal function in compensated hepatic cirrhosis: Effects of an amino acid infusion and relationship with nitric oxide
13. Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis
14. A micropuncture study of salt and water retention in chronic experimental cirrhosis
15. Impaired response to splanchnic infusion of hypertonic saline in conscious cirrhotic rats
16. Reduced papillary plasma flow in non-ascitic cirrhotic rats
17. Increased endothelium-dependent renal vasodilation in cirrhotic rats
18. Efectos de la inhibición de la síntesis de óxido nítrico en la hemodinámica y excreción renal de ratas con cirrosis biliar primaria
19. Papel del óxido nítrico en las alteraciones renales de la cirrosis hepática
20. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide
21. Renal effects of nitric oxide synthesis inhibition in cirrhotic rats
22. The role of nitric oxide on renal function: The control of blood pressure under normal conditions and during cirrhosis
23. Nitric oxide, the kidney and hypertension
24. Chronic effect of nitric oxide and prostaglandin inhibition on pressure diuresis and natriuresis in rats
25. Pressure natriuresis in nitric oxide-deficient hypertensive rats: Effect of antihypertensive treatments
26. Nitric oxide synthase inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites
27. Renal effects of chronic L-NAME and aminoguanidine in cirrhotic rats with ascites
28. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis
29. Intrarenal alterations in experimental liver cirrhosis
30. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation
31. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites
32. Renal and pressor effects of aminoguanidine in cirrhotic rats with ascites
33. Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation
34. 1 receptors in the acute and chronic effects of nitric oxide inhibition
35. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite and carbon dioxide
36. Renal functional alterations in extrahepatic cholestasis: Can oxidative stress be involved?
37. Lipoperoxide plasma levels in patients with liver cirrhosis
38. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats
39. Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice
40. Biochemical events associated with ligation of the common bile duct in Wistar rats
41. Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage
42. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis
43. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II
44. A receptors for endothelin regulation
45. Bile acids, oxidative stress and renal function in biliary obstruction
46. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
47. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
48. The isoprostanes: Unique bioactive products of lipid peroxidation
49. 2-isoprostane, on endothelin-1 release
50. 2a, in the rat. Evidence for interaction with thromboxane A2 receptors
51. Evidence for in vivo peroxynitrite production in human chronic hepatitis
52. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction
53. Enhanced lipid peroxidation in hepatic cirrhosis
54. Isoprostanes-prostaglandin-like compounds formed in vivo independently of cyclooxygenase: Use as clinical indicators of oxidant damage
55. Vitamin E improves systemic and renal hemodynamic and renal excretory function in bile duct ligated rats
56. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease
57. Micro-computed tomography of kidneys following chronic bile duct ligation
58. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography
59. Redistribution of renal blood flow in patients with liver cirrhosis
60. Intrarenal mechanism of salt retention after bile duct ligation in rats
61. Hepatorenal syndrome. Emerging perspectives of pathophysiology and therapy
62. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
63. 2-isoprostanes) in the hepatorenal syndrome
64. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat
65. Lipoid acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis
66. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine
67. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart
68. Attenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite in vivo
69. Peroxynitrite-mediated attenuation of α- and β-adrenoceptor agonist-induced vascular responses in vivo
70. The role of peroxynitrite in nitric oxide-mediated toxicity
71. The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury
72. Cardiac output at rest in Laennec's cirrhosis
73. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop
74. Impaired left ventricular function in alcoholic cirrhosis
75. Cardiac abnormalities in liver cirrhosis
76. Cirrhotic cardiomyopathy: Getting to the heart of the matter
77. Cardiopulmonary dysfunction in cirrhosis
78. Cirrhotic cardiomyopathy and liver transplantation
79. Effect of volume expansion on hemodynamics, capillary permeability, and renal function in conscious, cirrhotic rats
80. Desensitization of myocardial β-adrenergic receptors in cirrhotic rats
81. Limited cardiac preload reserve in conscious cirrhotic rats
82. Management of cirrhotic cardiomyopathy
83. NO and cardiac diastolic function
84. Regulation of cardiac β-adrenergic response by nitric oxide
85. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
86. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide
87. Regulation of ryanodine receptors by reactive nitrogen species
88. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy
89. Role of altered β-adrenergic receptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats
90. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy
91. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II in human heart failure
92. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related
93. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats
94. Cardiac impairment and nitric oxide synthase activity in the chronic portal vein-stenosed rat
95. Cardiac plasma membrane physical properties and beta-adrenergic receptor function are unaltered in portal hypertensive rats
96. Cardiac excitation-contraction coupling in the portal hypertensive rat
97. The heme oxygenase system: A regulator of second messenger gases
98. The heme oxygenase-carbon monoxide system: A regulator of hepatobiliary function
99. Hypothesis and preliminary data to suggest carbon monoxide as the mediator of the hyperdynamic circulation of cirrhosis?
100. Role of heme oxygenase pathway in pathogenesis of cirrhotic cardiomyopathy in the rat
101. Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: A mechanistic model
102. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: Stimulation by YC-1, nitric oxide, and carbon monoxide